Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003057 · ClinicalTrials.gov registry record · Phase 3
Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer
A Phase 3 study, sponsored by Eastern Cooperative Oncology Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 500
- Enrollment target
NCT00003057 is a Phase 3 study that has completed, run by Eastern Cooperative Oncology Group. The registered enrollment target is 500 participants.
The verdict
NCT00003057, a Phase 3 study, has completed, sponsored by Eastern Cooperative Oncology Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 500 participants
- Enrollment target
Study Summary
RATIONALE: Drugs such as octreotide and loperamide hydrochloride use different ways to relieve the diarrhea caused by chemotherapy. PURPOSE: Randomized phase III trial to compare the effectiveness of octreotide with loperamide hydrochloride for the treatment of chemotherapy-related diarrhea in patients who have colorectal cancer.
Interventions
- DRUG octreotide acetate
- DRUG loperamide hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 1997-03-26 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003057
The ClinicalTrials.gov registry entry for NCT00003057 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eastern Cooperative Oncology Group, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which octreotide acetate is the first listed.
NCT00003057 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003057 about?
NCT00003057 is a clinical study titled "Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer". RATIONALE: Drugs such as octreotide and loperamide hydrochloride use different ways to relieve the diarrhea caused by chemotherapy. PURPOSE: Randomized phase III trial to compare the effectiveness of octreotide with loperamide hydrochloride for the treatment of chemotherapy-related diarrhea in pati...
What is the current status of trial NCT00003057?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 500 participants. The study started on 1997-03-26.
What interventions are being tested in trial NCT00003057?
The interventions under investigation include: octreotide acetate (DRUG), loperamide hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00003057?
This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.